Combined positron emission tomography-computed tomography (PET-CT) has made a significant impact on cancer imaging. The use of CT to map tissue attenuation for correction of PET images and the ability to co-register the functional information provided by PET with the anatomical data afforded by CT, has resulted in demonstrable improvements in diagnostic accuracy. However, attenuation correction and anatomical localisation may not represent the full benefits of integrating CT with PET. The use of CT acquisition techniques for patient positioning and the use of contrast media can improve diagnostic performance, and incorporation of CT image processing techniques such as perfusion CT, 3D imaging and computer-assisted diagnosis offers new applications. The interpretation of PET-CT images can be improved by fully integrating the morphological appearances on CT into image analysis. Better utilisation of the CT component of PET-CT could further enhance the benefits of PET-CT in oncology but will have implications for manufacturers and purchasers of PET-CT equipment and analysis software. Furthermore, specialists working in PET-CT will need CT competencies beyond knowledge of cross-sectional anatomy. CT continues to exhibit rapid evolution and these advances will inevitably impact on the practice of PET-CT.

Author

K.A. Miles

Contact Details

Corresponding address:
Ken Miles, Professor of Imaging, Brighton & Sussex Medical School, Brighton, BN1 9RR, UK

Reference

ICIS Cancer Imaging Volume 8 Special Issue A
DOI: 10.1102/1470-7330.2008.9015

Date Posted

4 October 2008

Print PDF

Size

1.11 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	4 seconds
ADSL 512Kb/s (Broadband):	17 seconds
64 Kb/s (ISDN):	2 minutes 22 seconds
33.3 Kb/s (Typical Modem):	4 minutes 33 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 66356, London, E14 1GW. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.